Gemcitabine-based chemotherapy for advanced biliary tract carcinomas
OBJECTIVES: This is a protocol for a Cochrane review (intervention). The objectives are as follows: To assess the benefits and harms of intravenous administration of gemcitabine monotherapy or gemcitabine-based combination chemotherapy versus placebo or non-gemcitabine-based chemotherapy in people with advanced biliary tract carcinomas.
Authors
- Atalel Fentahun Awedew (ORCID: https://orcid.org/0000-0001-8611-599X)
- Assefa Fentahun Emrie
- Mihretu Jegnie
- Luis Morales
- supported by the Cochrane Hepato-Biliary Group
Institutions
- Debre Berhan University (ET)
- Debre Tabor University (ET)
- University of Colorado Anschutz Medical Campus (US)
Publication Details
- Journal
- Cochrane Database of Systematic Reviews
- Published
- 2026-08-17
- DOI
- https://doi.org/10.1002/14651858.cd016126
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00